Skip to main content

Table 1 Prevalence of NIV and long-term oxygen treatment in Helsinki University Hospital Area on 1.1.2018

From: The prevalence of non-invasive ventilation and long-term oxygen treatment in Helsinki University Hospital area, Finland

Prevalence per 100,000* All patients COPD NMD RCWD OHS ILD Misc**
NIV
(N = 362)
26.7 3.4 6.0 2.4 13.3 0.1 1.6
LTOT
(N = 335)
24.6 12.4 0.1 0.4 0.2 5.1 6.3
NIV + LTOT
(N = 118)
8.7 4.1 0.1 1.1 2.5 0.1 0.7
All NIV and/or LTOT treatments
(N = 815)
60.0 20.0 6.3 4.0 16.0 5.3 8.5
  1. COPD, chronic obstructive pulmonary disease; NMD, neuromuscular disease; RCWD, restrictive chest wall disease; OHS, obesity-hypoventilation syndrome; ILD, interstitial lung disease; Misc, miscellaneous; NIV, non-invasive ventilation; LTOT, long-term oxygen treatment
  2. *Children under 16, patients with invasive mechanical ventilation or sleep apnea are excluded from the study
  3. **Misc group includes heart disease and cancer patients